Medical Non-invasive Ventilator (NIV) Market Size 2023: Analysis by Key Players till 2028

Newest Research on “Medical Non-invasive Ventilator (NIV) Market” – Forecast by Top Regions 2023-2028

Non-invasive ventilation (NIV) means breathing support is delivered through a non-invasive method, like a nasal mask, instead of an invasive approach, like a tracheostomy. The NIV machine helps fully inflate the lungs, improving blood oxygen levels and reducing carbon dioxide levels. NIV can also help improve sleep quality and alleviate symptoms that may result from low levels of oxygen or accumulated carbon dioxide like morning headaches, daytime fatigue and shortness of breath.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of Percent during the forecast period 2022-2028.
The USA market for Medical Non-invasive Ventilator (NIV) is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of Percent during the forecast period of 2023 through 2028.
The China market for Medical Non-invasive Ventilator (NIV) is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of Percent during the forecast period of 2023 through 2028.
The Europe market for Medical Non-invasive Ventilator (NIV) is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of Percent during the forecast period of 2023 through 2028.
The global key manufacturers of Medical Non-invasive Ventilator (NIV) include Resmed, Medtronic, BD, Philips Healthcare, GE Healthcare, Getinge Group, Teijin Pharma, Fisher & Paykel and Draeger, etc. In 2021, the global top five players had a share approximately Percent in terms of revenue.

Major Product Types of Medical Non-invasive Ventilator (NIV) covered are: